1 / 1

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 mill

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.<br><br>Roots Analysis is pleased to announce the publication of its recent study, titled, u201cLive Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030.u201d<br>For more information please click on the following link:<br>https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html<br>

kevin987
Download Presentation

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 mill

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related